No image available.
A .gov website belongs to an official government organization in the United States. A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. CDC, the U.S. Food and Drug Administration (FDA), America’s Poison Centers, and state and local partners are investigating reports of severe acute illnesses potentially associated with consuming Diamond ShruumzTM brand chocolate bars, cones, and gummies marketed as containing a proprietary blend of mushrooms. CDC and FDA have received reports of severe acute illnesses and other adverse effects following consumption of Diamond ShruumzTM brand chocolate bars, cones, and gummies reported to multiple poison control centers across the United States. As of October 31, 2024, 180 total illnesses, including 73 hospitalizations, were reported in 34 U.S. states. There were three (3) potentially associated deaths. On June 25, 2024, FDA released information regarding test results for product samples (see information below). The cause of the reported illnesses is not known at this time. People should not buy or eat any flavors of Diamond ShruumzTM brand chocolate bars, cones, or gummies, and should discard products that have been purchased. *The case definition used by state health departments for the reported illnesses is as follows: Illness with moderate or major clinical effects, or death, occurring in a person who ate any Diamond Shruumz product (chocolate bars, cones, gummies or other) or another chocolate product marketed as containing mushrooms, during January 1, 2024, through the present. *The case definition used by state health departments for the reported illnesses is as follows: Illness with moderate or major clinical effects, or death, occurring in a person who ate any Diamond Shruumz product (chocolate bars, cones, gummies or other) OR another chocolate product marketed as containing mushrooms, during January 1, 2024, through the present. On June 27, 2024, Prophet Premium Blends, LLC of Santa Ana, CA, initiated a recall of all flavors of Diamond ShruumzTM brand chocolate bars, cones, and gummies. Diamond ShruumzTM brand products have been distributed online and at retailers, including those that sell hemp-derived (e.g., cannabidiol [CBD], delta-8 tetrahydrocannabinol [THC]) and smoke/vape products nationwide. Products containing psychoactive compounds such as cannabis or mushroom extracts are increasing in availability. These “edibles” are often sold as gummy candies, chocolates, or other snack foods. They might contain undisclosed ingredients, including illicit substances, other adulterants, or potentially harmful contaminants that are not approved for use in food. As part of this investigation, FDA and state partners collected samples of Diamond ShruumzTM brand products for testing and analysis. As of November 4, 2024, FDA testing on several Diamond ShruumzTM brand products identified the presence of multiple substances, including O-acetylpsilocin, psilocin, kavalactones, pregabalin, and muscimol: There may be variability in test results across products with different formulations as well as potential variability across lots and batches of the same product. FDA and CDC medical officers are interpreting these test results to understand the health risks of ingesting these chemical substances and to determine the appropriate next steps. For additional information about FDA testing and analysis, please visit the FDA website: Investigation of Illnesses: Diamond Shruumz-Brand Chocolate Bars, Cones, & Gummies (June 2024). A variety of severe health effects have been reported after consumption of Diamond ShruumzTM brand products, including the following: Other symptoms people have experienced include the following: Contact your health care provider or Poison Help Line (1-800-222-1222) if you have symptoms. Many hallucinogenic mushrooms (also known as “magic mushrooms” or “shrooms”) contain psilocybin, a Schedule 1 substance under the Controlled Substances Act that has a high potential for abuse. Psilocybin can temporarily alter a person’s mood, thoughts, and perceptions. Substances such as O-acetylpsilocin (identified during testing of above products), psilocybin, psilocin, dimethyltryptamine (DMT), and lysergic acid diethylamide (LSD) all have similar chemical structures. Individuals who use these substances can experience hallucinations, visual illusions, and other sensory changes. Some patients may have adverse effects such as nausea, vomiting, fast heart rate, anxiety, agitation, lightheadedness, or tremor. Muscimol is a chemical that can be found in the fly agaric mushroom, Amanita muscaria, and other related mushrooms such as the panther cap, Amanita pantherina. These mushrooms are sometimes consumed intentionally for psychotropic effects, altering a person’s mood, thoughts, and emotions. Ingestion of A. muscaria can cause symptoms including hallucinations, drowsiness, and dizziness. Kava is a plant (Piper methysticum) cultivated in some Pacific Islands. It contains the kavalactones mentioned above (desmethoxyyangonin, dihydrokavain, and kavain) and other compounds. Ingestion of kava can cause numbness of the mouth and skin, loss of coordination, dizziness, and sedation. Ingestion of kava with other substances known to cause sedation, such as benzodiazepines or alcohol, can worsen sedation. Kava can also cause gastrointestinal effects such as nausea and vomiting. Chronic or heavy ingestion of kava has been occasionally associated with certain skin conditions and liver toxicity. Management of ingestions of these substances is supportive in nature. Patients may require benzodiazepines or other sedative medications for seizures and intravenous fluids or vasopressors for hypotension. Patients with major symptoms of sedation or seizures who are unable to protect their airway may require endotracheal intubation. Additional information for clinicians and public health professionals can be found in the CDC Health Alert Network Advisory: Health Alert Network (HAN) – 00509: Severe Illness Potentially Associated with Consuming Diamond ShruumzTM Brand Chocolate Bars, Cones, and Gummies. CDC conducts epidemiologic studies to better understand the relationship between human health and environmental exposures. Languages Language Assistance
Attribution:
This article was summarized and republished from the original source.
Please check the original article here: https://www.cdc.gov/environmental-health-studies/outbreak-investigation-diamond-shruumz-products/index.html.